Michelle Afkhami, MD, of City of Hope, joins The American Journal of Managed Care® (AJMC®) for a discussion on EGFR exon 20 insertion positive mutations in non-small cell lung cancer. Michelle Afkhami ...

“The goal of our study was to investigate the influence of HER2 and uncommon EGFR mutation subtypes and their clinical outcomes in patients treated with ICIs compared to canonical EGFR sensitizing ...